PKM and non-small cell lung carcinoma: Upon specific phosphorylation by pyruvate kinase M2 (PKM2), an overexpressed biomarker of NSCLC, Nap‐T is gradually converted to Nap–Phe–Phe–Phe–Lys–Ser–Thr(H2PO3)–Gly–Gly–Lys–Ala–Pro–Arg–OH (Nap‐Tp), leading to dehydrogelation and sustained release of PTX and GDC0919 within NSCLC tissues.